Browse by Journal Title

2012

Novel Clostridium perfringens enterotoxin suicide gene therapy for selective treatment of claudin-3- and -4-overexpressing tumors.
Walther, W., Petkov, S., Kuvardina, O.N., Aumann, J., Kobelt, D., Fichtner, I., Lemm, M., Piontek, J., Blasig, I.E., Stein, U. and Schlag, P.M.
Gene Therapy 19 (5): 494-503. May 2012

2011

The hyperactive Sleeping Beauty transposase SB100X improves the genetic modification of T cells to express a chimeric antigen receptor.
Jin, Z., Maiti, S., Huls, H., Singh, H., Olivares, S., Mates, L., Izsvak, Z., Ivics, Z., Lee, D.A., Champlin, R.E. and Cooper, L.J.
Gene Therapy 18 (9): 849-856. September 2011

Allogeneic gene-modified tumor cells (RCC-26/IL-7/CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I study.
Westermann, J., Floercken, A., Willimsky, G., van Lessen, A., Kopp, J., Takvorian, A., Joehrens, K., Lukowsky, A., Schoenemann, C., Sawitzki, B., Pohla, H., Frank, R., Doerken, B., Schendel, D.J., Blankenstein, T. and Pezzutto, A.
Gene Therapy 18 (4): 354-363. April 2011

2007

In vivo splenic CD11c cells downregulate CD4 T-cell response thereby decreasing systemic immunity to gene-modified tumour cell vaccine.
Cayeux, S., Bukarica, B., Buschow, C., Charo, J., Bunse, M., Doerken, B. and Blankenstein, T.
Gene Therapy 14 (20): 1481-1491. October 2007

Suspension packaging cell lines for the simplified generation of T-cell receptor encoding retrovirus vector particles.
Reuß, S., Biese, P., Cosset, F.L., Takeuchi, Y. and Uckert, W.
Gene Therapy 14 (7): 595-603. April 2007

2006

Conditional gene expression: Intelligent designs.
Gossen, M.
Gene Therapy 13 (17): 1251-1252. September 2006

2004

A sensitive noninvasive method for monitoring successful liver-directed gene transfer of the low-density lipoprotein receptor in Watanabe hyperlipidemic rabbits in vivo.
Tietge, U.J.F., Cichon, G., Buettner, C., Genschel, J., Heeren, J., Gielow, P., Grewe, N., Dogar, M., Beisiegel, U., Manns, M.P., Lochs, H., Burchert, W. and Schmidt, H.H.J.
Gene Therapy 11 (7): 574-580. April 2004

Flt-3 ligand as adjuvant for DNA vaccination augments immune responses but does not skew TH1/TH2 polarization.
Westermann, J., Nguyen-Hoai, T., Mollweide, A., Richter, G., Schmetzer, O., Kim, H.J., Blankenstein, T., Doerken, B. and Pezzutto, A.
Gene Therapy 11 (13): 1048-1056. 1 January 2004

2003

Titer determination of Ad5 in blood: a cautionary note.
Cichon, G., Boeckh-Herwig, S., Kuemin, D., Hoffmann, C., Schmidt, H.H., Wehnes, E., Haensch, W., Schneider, U., Eckhardt, U., Burger, R. and Pring-Akerblom, P.
Gene Therapy 10 (12): 1012-1017. June 2003

Coexpression of p21WAF1/CIP1 in adenovirus vector transfected human primary hepatocytes prevents apoptosis resulting in improved transgene expression.
Wolff, G., Schumacher, A., Nuessler, A.K., Ruppert, V., Karawajew, L., Wehnes, E., Neuhaus, P. and Doerken, B.
Gene Therapy 10 (8): 668-677. April 2003

2002

Adenoviral transduction of tumor cells induces apoptosis in co-cultured T lymphocytes.
Scholz, C., Staerck, L., Willimsky, G., Blankenstein, T., Doerken, B. and Daniel, P.T.
Gene Therapy 9 (21): 1438-1446. November 2002

Utilization of synthetic peptides containing nuclear localization signals for nonviral gene transfer systems.
Cartier, R. and Reszka, R.
Gene Therapy 9 (3): 157-167. 1 February 2002

2001

Complement activation by recombinant adenoviruses.
Cichon, G., Boeckh-Herwig, S., Schmidt, H.H., Wehnes, E., Mueller, T., Pring-Akerblom, P. and Burger, R.
Gene Therapy 8 : 1794-1800. 1 December 2001

MHC class II presentation of endogenously expressed antigens by transfected dendritic cells.
Diebold, S.S., Cotten, M., Koch, N. and Zenke, M.
Gene Therapy 8 (6): 487-493. 1 January 2001

Nonviral in vivo gene delivery into tumors using a novel low volume jet-injection technology.
Walther, W., Stein, U., Fichtner, I., Malcherek, L., Lemm, M. and Schlag, P.M.
Gene Therapy 8 (3): 173-180. 1 January 2001

2000

Expression of B7.1 (CD80) in a renal cell carcinoma line allows expansion of tumor-associated cytotoxic T lymphocytes in the presence of an alloresponse.
Schendel, D.J., Frankenberger, B., Jantzer, P., Cayeux, S., Noessner, E., Willimsky, G., Maget, B., Pohla, H. and Blankenstein, T.
Gene Therapy 7 (23): 2007-2014. 1 December 2000

Ovine adenovirus vectors mediate efficient gene transfer to skeletal muscle.
Loeser, P., Hillgenberg, M., Arnold, W., Both, G.W. and Hofmann, C.
Gene Therapy 7 : 1491-1498. 1 September 2000

1998

Tumor cell-specific transgene expression prevents liver toxicity of the adeno-HSVtk/GCV approach.
Brand, K., Loeser, P., Arnold, W., Bartels, T. and Strauss, M.
Gene Therapy 5 : 1363-1371. 1 October 1998

Baculovirus-mediated gene transfer in the presence of human serum or blood facilitated by inhibition of the complement system.
Hofmann, C. and Strauss, M.
Gene Therapy 5 (4): 531-536. 1 April 1998

Transient immunosuppression with 15-deoxyspergualin prolongs reporter gene expression and reduces humoral immune response after adenoviral gene transfer.
Cichon, G. and Strauss, M.
Gene Therapy 5 : 85-90. 1 January 1998

Retroviral interleukin-7 gene transfer into human dendritic cells enhances T cell activation.
Westermann, J., Aicher, A., Qin, Z., Cayeux, S., Daemen, K., Blankenstein, T., Doerken, B. and Pezzutto, A.
Gene Therapy 5 : 264-271. 1 January 1998

1997

Loss of retroviral gene expression in bone marrow reconstituted mice correlates with down regulation of gene expression in long term culture initiating cells.
Lange, C. and Blankenstein, T.
Gene Therapy 4 : 303-308. 1 January 1997

Employment of the mdr1 promoter for the chemotherapy-inducible expression of therapeutic genes in cancer gene therapy.
Walther, W., Wendt, J. and Stein, U.
Gene Therapy 4 : 544-552. 1 January 1997

H1 and HMG17 extracted from calf thymus nuclei are efficient DNA carriers in gene transfer.
Zaitsev, S.V., Haberland, A., Otto, A., Vorob'ev, V.I., Haller, H. and Boettger, M.
Gene Therapy 4 : 586-592. 1 January 1997

1996

HBV-derived promoters direct liver-specific expression of an adenovirally transduced LDL receptor gene.
Sandig, V., Loeser, P., Lieber, A., Kay, M.A. and Strauss, M.
Gene Therapy 3 (11): 1002-1009. October 1996

Effect of amniotic fluid on cationic lipid mediated transfection and retroviral infection.
Douar, A.M., Themis, M., Sandig, V., Friedmann, T. and Coutelle, C.
Gene Therapy 3 (9): 789-796. September 1996

A continuous intracerebral gene delivery system for in vivo liposome mediated gene therapy.
Zhu, J., Zhang, L., Hanisch, U.K., Felgner, P.L. and Reszka, R.
Gene Therapy 3 (6): 472-476. June 1996

Cancer vaccines in gene therapy.
Blankenstein, T. and Qin, Z.
Gene Therapy 3 (2): 95-96. 1 January 1996

1994

Liver-directed gene therapy: prospects and problems.
Strauss, M.
Gene Therapy 1 (3): 156-164. 1 May 1994